INS and non-alcoholic fatty liver: Outcomes from a lifestyle intervention trial involving insulin-sensitive and insulin-resistant adults with non-alcoholic fatty liver (NAFL) showed that LPC 16:0 was higher in the insulin-sensitive group and may serve as a biomarker for insulin sensitivity in individuals with NAFL [127].